Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Health product
Remove filter for
Issue: Health products
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 717 items.
UPDATED INFORMATION – January 20, 2023
On January 10, 2023, following a Federal Court of Appeal decision, the June 24, 2021 decision of the Minister of Health on the application of the data protection provisions was restored, and a new Notice of…
AlertHealth professional risk communication | 2023-01-20
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
UPDATED INFORMATION – 2023/01/17
Neutralization data for the following SARS-CoV-2 Omicron subvariants have been added to the Canadian Product Monograph: Omicron BA.2.75.2, BF.7, BJ.1, BN.1, BQ.1, BQ.1.1, and XBB. See Table 1 (below) for a summary…
AlertHealth professional risk communication | 2023-01-17
The concentration of the medicinal ingredient, sodium fluoride, is out of specification in the affected lot.
RecallHealth product recall | 2022-12-15
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit.
OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2022-12-05
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
Health Canada authorized SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) on November 3, 2022. In order to provide rapid access to the vaccine, Moderna will distribute product vials and cartons labelled in English only with the…
AlertHealth professional risk communication | 2022-11-18
Affected lot may result in a false negative for skin test (peanut allergy)
RecallHealth product recall | 2022-11-15
Intravenous bag may be leaking in affected lots.
RecallHealth product recall | 2022-11-03